Bank of Montreal
ONCT

Bank of Montreal’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bank of Montreal’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,488
Closed -$686K – 3966
2021
Q3 		$686K Sell
8,488
-435
-5% -$36K ﹤0.01% 2689
2021
Q2 		$857K Buy
8,923
+2,536
+40% +$301K ﹤0.01% 2577
2021
Q1 		$1.19M Buy
+6,387
New +$845K ﹤0.01% 2062
2019
Q3 		– Hold
0
– – – 5055
2019
Q2 		– Hold
0
– – – 5123
2019
Q1 		– Sell
-367
Closed -$54.7K – 4855
2018
Q4 		$40K Buy
+367
New +$73.4K ﹤0.01% 3376
2018
Q3 		– Hold
0
– – – 4938
2018
Q2 		– Hold
0
– – – 4618
2014
Q3 		– Hold
0
– -$1K – 4488
2014
Q2 		– Hold
0
– – – 4595

Other funds holding ONCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Bank of Montreal's ONCT Position: Q4 2021 in Review

Bank of Montreal sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2021, closing a stake of 8,488 shares — an estimated $686K sold.

Bank of Montreal first reported a position in ONCT in Q4 2018 and held it in 4 quarters. The position peaked at $1.19M in Q1 2021. 82 funds tracked by Wall St. Rank hold ONCT as of Q4 2021.

  • Bank of Montreal reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 8,488 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $686K.
  • Bank of Montreal first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • Bank of Montreal's Oncternal Therapeutics, Inc. Common Stock position peaked at $1.19M in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.